From January 1, 2022 to March 31, 2022, the company has repurchased 26,000 shares, representing 0.02% for CNY 5.11 million. With this, the company has completed the repurchase of 360,000 shares, representing 0.27% for CNY 60.99 million under the buyback announced on October 29, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.64 CNY | -1.19% |
|
-5.22% | -34.69% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.69% | 924M | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 29, 2021.